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who received active treatment lived longer than those who received 
the best supportive care (NSCLC: 12 vs. 4 months, p=0.015, Figure 1; 
SCLC: 14 vs. 5 months, p=0.02, Figure 2).
There was a similar response to chemotherapy between the elderly and 
non-elderly patients (NSCLC: p=0.386; SCLC: p=0.172). 
Conclusion: Even though elderly patients have a poor performance 
status compared with non elderly patients, chemotherapy improves the 
overall survival time and response rate in eligible patients. 
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Introduction: We frequently encounter patients with lung cancer who 
have impaired lung function and co-morbidity that place them at high 
risk for surgery. Signiﬁcant toxicity arising from stereotatic body radia-
tion therapy for central airway cancers was recently been reported. 
Aim: To determine efﬁcacy of bronchoscopic treatment (BT) for early 
intraluminal squamous cell cancers (ISCC) in patients unﬁt for surgery. 
Methods: Patients suspected of lung cancer underwent autoﬂuores-
cence bronchoscopy (AF) and data on demographics, smoking, pack 
years, comorbidity, therapy, and outcome were prospectively collected 
and entered into database since 1996. 
Results: There were 60 current and former smokers of 40 pack years 
(range, 32-50), 47 males, with median age 69 years (range, 64-75). 
Forty seven patients (78%) had moderate to very severe COPD and 19 
(32%) with coronary heart disease. All had early ICSS conﬁned within 
the airway wall deﬁned initially by high resolution CT at 1 mm, and 
subsequently by multidetector CT at 0.75 mm slices. As they were all 
considered non-resectable or marginally resectable surgical candidates, 
29 satisﬁed the criteria of radiographically occult cancers with visible 
tumor margins and size ≤1cm2 whilst the other 31 patients who were 
matched in age and comorbidity, had tumor margins that extended be-
yond visibility of AF. All underwent BT with endobronchial electrosur-
gery or cryotherapy. Median follow up was 40 months (range, 21-73), 
and no toxicity or death related to BT was observed. Lung cancer 
related mortality was 18%. Kaplan-Meier survival of both groups are 
shown (p=0.19).
Conclusion: BT is a safe alternative for patients with centrally located 
early ISCC who are precluded from or at risk for curative surgery due 
to their signiﬁcant comorbidity.
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Background: Most of patients (pts) with lung cancer are not candi-
dates for curative surgery at time of diagnosis. Aims of our study were 
to describe the recent situation with diagnostics and therapeutical 
modalities and to look for reasons of low operability of lung cancer in 
the Czech Republic.
Methods: A retrospective study on 272 consecutive lung cancer pts. A 
special attention was paid to the relation between smoking status and 
the onset of lung cancer, to the coincidence with COPD and correlation 
of bronchoscopic ﬁndings with other pts characteristics. 
Results: 184 men and 88 women (ratio 2:1) were studied. There were 
60 % of recent smokers, 24 % of ex-smokers and 16 % of never smok-
ers. Lung cancer was diagnosed in signiﬁcantly earlier age in smokers 
(median age men 65, women 61 years) than in ex-smokers (median age 
men and women 73 years). Men smoked statistically more cigarettes 
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then women. More earlier stages of lung cancer were diagnosed in pts 
with COPD. In pts with direct tumor changes found during bronchosco-
py was tumor veriﬁed in 95%, with indirect tumor changes in 54% and 
in pts with normal bronchoscopy in 20%. Morphological types of lung 
cancer was assessed in 216 pts. Squamous cell and adenocarcinoma 
were the most frequent types, in 23% resp. in 20%. Adenocarcinoma 
was the most frequent type in nonsmoking pts (22 %). 91 pts (34 %) 
were diagnosed in potentially resectable stages I - IIIA, however only 
42 pts underwent surgery, 7 of them in higher stages. The reasons for 
inoperability in 56 potentially resectable pts were as follows: age over 
80 years with polymorbidity in 12, bad general status in 10, COPD 
stage III-IV in 9, congestive heart failure in 5, refusing of surgery in 5 
pts and other reasons in 15.
Conclusions: The diagnosis of lung cancer was late in 67 % of studied 
pts. Lung cancer was diagnosed in signiﬁcantly lower age in current 
smokers and in earlier stages in COPD pts. The most frequent reasons 
for inoperability in potentially operable pts were severe COPD and 
polymorbidity. Pts with direct tumor changes found during bronchos-
copy were veriﬁed in 93%, with normal ﬁndigs in 20%.
Clinical Implications: Information about the lower age of onset of 
lung cancer in current smokers, about coincidence of earlier stages of 
lung cancer with COPD and stated probability of veriﬁcation during 
bronchoscopy may help to physicians to improve the diagnosis of lung 
cancer.
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Background: Tyrosine kinase domain (TKD) gene mutations of the 
epidermal growth factor receptor (EGFR) have reported to be clini-
cally important in non-small cell lung cancer (NSCLC). However, 
relationships between EGFR TKD mutations and respiratory function 
or radiological imaging in adjacent lung tissue have not ever evaluated. 
The purpose of this study was to elucidate the correlations between 
EGFR TKD mutations and some respiratory parameters by spirometry 
or ﬁndings of chest computed tomography (CT) in NSCLC. 
Methods: A total of 88 consecutive Japanese patients with NSCLC 
were preoperatively examined spirometry in the Department of 
Laboratory Medicine, chest CT in the Department of Radiology, and 
underwent surgery in the Department of Thoracic Surgery at Kyorin 
University Hospital between January 2001 and December 2003. Forced 
expiratory volume in one second (FEV1.0) / forced vital capacity 
(FVC) (FEV1.0%, low FEV1.0% < 70%, normal FEV1.0% ≥ 70%) 
and diffuse capacity of the lung for carbon monoxide (DLCO) per unit 
of alveolar volume (VA) / predicted DLCO/VA (%DLCO/VA, low 
%DLCO/VA < 70%, normal %DLCO/VA ≥ 70%) evaluated as parame-
ters for respiratory function, and emphysematous or ﬁbrotic appearance 
in adjacent lung tissue on chest CT was integrated into the analysis. We 
investigated EGFR TKD mutations using direct sequencing in samples 
from 88 NSCLC patients, and the correlations with respiratory function 
or imaging in adjacent lung on chest CT was analyzed. 
Results: EGFR TKD mutations were detected in 25 of 88 NSCLC 
(28%). Presence of EGFR TKD mutations was signiﬁcantly correlated 
with adenocarcinoma histology (p=0.004), but not sex, smoking status, 
age, and tumor staging by multivariate analysis. By univariate analysis, 
EGFR TKD mutations were signiﬁcantly related with normal FEV1.0% 
(p=0.017), normal %DLCO/VA (p=0.004), and no emphysematous 
(p=0.001) or no ﬁbrotic appearance (p=0.014) on chest CT. Among 
these factors, EGFR TKD mutations were signiﬁcantly correlated with 
normal FEV1.0% (p=0.048) by multivariate analysis. 
Conclusions: These results suggest that EGFR TKD mutations are 
associated with good respiratory function such as normal FEV1.0% in 
NSCLC patients. We consider that the correlation may be very impor-
tant to investigate into a role in pathogenesis of NSCLC with mutated 
EGFR TKD gene. 
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Talc pleurodesis is the safe and effective treatment for recurrent malig-
nant pleural effusion but acute hypoxemia, pulmonary edema or acute 
respiratory failure could develop in small number of patients.
We report 2 cases who developed fatal hypoxemia after talc pleurode-
sis. The ﬁrst case was 18-year old male who was diagnosed of Ewing’s 
sarcoma with bilateral lung metastasis and pleural effusion. The 
performance status was ECOG (Eastern Cooperative oncology Group, 
ECOG) grade 3. Ten hours after the second talc pleurodesis on the right 
side for uncontrolled pleural effusion, fever developed, along with 
hypoxemia and leukocytosis and the patient ﬁnally died of respiratory 
failure after 13 days. The second case was 66-year old female who 
was diagnosed of non-small cell lung cancer with bone metastasis. 
Two weeks after systemic chemotherapy, she complained of dyspnea, 
and pleural effusion on the right side was observed. Her performance 
status was ECOG grade 3. Talc pleurodesis was performed for recurrent 
pleural effusion, and hypoxemia developed 6 days after pleurodesis and 
died 10days after pleurodesis due to respiratory failure.
In conclusion, talc pleurodesis should be performed very carefully in 
patients with poor performance status, in cases of repeated pleurodesis, 
bilateral pleural effusion, recent chemotherapy, radiotherapy and when 
parenchymal metastatic lesions are present.
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Introduction: Transthoracic Needle Aspiration Biopsy was ﬁrst 
performed 120 years ago. Technique performance improvement and 
